Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?

• Үндсэн зохиолчид: Sungha Park (Зохиогч), Hae Young Lee (Зохиогч), Eun Joo Cho (Зохиогч), Ki Chul Sung (Зохиогч), Juhan Kim (Зохиогч), Dae-Hee Kim (Зохиогч), Sang-Hyun Ihm (Зохиогч), Kwang-il Kim (Зохиогч), Il-Suk Sohn (Зохиогч), Wook-Jin Chung (Зохиогч), Hyeon Chang Kim (Зохиогч), Sung Kee Ryu (Зохиогч), Wook Bum Pyun (Зохиогч), Jinho Shin (Зохиогч), on behalf of the Korean Society of Hypertension (Зохиогч)
• Формат: Ном
• Хэвлэсэн: BMC, 2020-05-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Abstract Antihypertensive drugs are one of the most widely used pharmacologic agent in the world and it is predominantly used in the elderly subjects. Pneumonia is the most common cause of death in the extremely old subject. During infection and its complication such as sepsis, hypotension could be...